Case studies

Hovione - TwinCaps® inhaler

In response to the 2006 global threat of a flu pandemic, Hovione was asked to develop and manufacture an inhalation device capable of delivering an influenza anti-viral drug.

  • Client

The world’s best-selling, disposable inhaler


Hovione came to TTP with a clear brief and a device requirement matched to a single formulation for the Japanese market.

In order to meet tight commercial timelines driven by the Japanese government’s flu pandemic fears, we needed a project plan that went from concept generation to first moulded prototypes in less than two months.

TTP assembled a small, dedicated team to leverage core knowledge of design and manufacturing principles to take on the challenge.

Our response was TwinCaps®: a two-component, single-dose, dry powder inhaler for systemic delivery.

Focusing on one design concept, and by means of early and repeated prototyping coupled with a concurrent engineering approach, TTP was able to meet the incredibly short product launch deadlines.

Hovione Inuse

Launched by Daiichi Sankyo, Japan’s second largest pharmaceutical company, TwinCaps® outsold Relenza and Tamiflu within the first six months and is the world’s best-selling, disposable inhaler.

Get in touch

Next up

K-Haler® inhaler taking innovation into production

TTP routinely creates and applies new technologies, and much of our success is down to the fact that we are able to turn these new technologies into manufacturable products.

  • Client

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.